Equity and Redeemable Noncontrolling Interests - ATM Program (Details) - USD ($)		1 Months Ended	12 Months Ended
	Apr. 30, 2021	May 31, 2021	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Subsidiary or Equity Method Investee [Line Items]
Issuance of common stock, net			$ 309,417,000	$ 1,745,000	$ 1,067,071,000
At-The-Market Program
Subsidiary or Equity Method Investee [Line Items]
Aggregate amount authorized	$ 1,250,000,000	$ 1,500,000,000
Aggregate amount remaining			$ 1,180,000,000
Maximum shares issuable under forward equity sales agreement (in shares)			9,100,000	9,100,000	2,000,000
Forward rate per share (in dollars per share)			$ 34.01	$ 35.25	$ 35.23
Settlement alternatives, fair value (in shares)				0
Forward contract, outstanding (in shares)			0		0
Issuance of common stock, net			$ 308,000,000
At-The-Market Program | Previous 2019 ATM Program
Subsidiary or Equity Method Investee [Line Items]
Forward rate per share (in dollars per share)					$ 31.38
Settlement alternatives, fair value (in shares)					16,800,000
Issuance of common stock, net					$ 528,000,000
At-The-Market Program | Minimum
Subsidiary or Equity Method Investee [Line Items]
Option indexed to issuers equity, term			1 year
At-The-Market Program | Maximum
Subsidiary or Equity Method Investee [Line Items]
Option indexed to issuers equity, term			2 years
ATM Direct Issuances | Common Stock
Subsidiary or Equity Method Investee [Line Items]
Issuance of common stock, net (in shares)			0	0	0